These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 35527171)

  • 1. Determinants of glycemic control in type 2 diabetes mellitus in Brazil: A sub-analysis of the longitudinal data from the BrazIian type 1 & 2 diabetes disease registry (BINDER).
    Moreira RO; Vianna AGD; Ferreira GC; de Paula MA
    Prim Care Diabetes; 2022 Aug; 16(4):562-567. PubMed ID: 35527171
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Patient characteristics and 6-month dose of basal insulin associated with HbA1c achievement <7.0% in Chinese people with type 2 diabetes: results from the Observational Registry of Basal Insulin Treatment (ORBIT).
    Gao L; Zhang P; Weng J; Lu J; Guo X; Jia W; Yang W; Zou D; Zhou Z; Pan C; Gao Y; Li X; Zhu D; Wu Y; Garg SK; Ji L
    J Diabetes; 2020 Sep; 12(9):668-676. PubMed ID: 32329194
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prevalence and correlation of glycemic control achievement in patients with type 2 diabetes in Iraq: A retrospective analysis of a tertiary care database over a 9-year period.
    Mansour AA; Alibrahim NTY; Alidrisi HA; Alhamza AH; Almomin AM; Zaboon IA; Kadhim MB; Hussein RN; Nwayyir HA; Mohammed AG; Al-Waeli DKJ; Hussein IH;
    Diabetes Metab Syndr; 2020; 14(3):265-272. PubMed ID: 32272433
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Real-world Canagliflozin Utilization: Glycemic Control Among Patients With Type 2 Diabetes Mellitus-A Multi-Database Synthesis.
    Chow W; Miyasato G; Kokkotos FK; Bailey RA; Buysman EK; Henk HJ
    Clin Ther; 2016 Sep; 38(9):2071-82. PubMed ID: 27596020
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antidiabetic Treatment, Level of Glycemic Control, and Risk of Fracture in Type 2 Diabetes: a Nested, Case-Control Study.
    Charlier S; Vavanikunnel J; Becker C; Jick SS; Meier C; Meier CR
    J Clin Endocrinol Metab; 2021 Jan; 106(2):554-566. PubMed ID: 33141149
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of Subcutaneous Tirzepatide vs Placebo Added to Titrated Insulin Glargine on Glycemic Control in Patients With Type 2 Diabetes: The SURPASS-5 Randomized Clinical Trial.
    Dahl D; Onishi Y; Norwood P; Huh R; Bray R; Patel H; Rodríguez Á
    JAMA; 2022 Feb; 327(6):534-545. PubMed ID: 35133415
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluation of an mHealth-enabled hierarchical diabetes management intervention in primary care in China (ROADMAP): A cluster randomized trial.
    Jia W; Zhang P; Zhu D; Duolikun N; Li H; Bao Y; Li X;
    PLoS Med; 2021 Sep; 18(9):e1003754. PubMed ID: 34547030
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Association of Longitudinal Values of Glycated Hemoglobin With Cardiovascular Events in Patients With Type 2 Diabetes and Multivessel Coronary Artery Disease.
    Rezende PC; Hlatky MA; Hueb W; Garcia RMR; da Silva Selistre L; Lima EG; Garzillo CL; Scudeler TL; Boros GAB; Ribas FF; Serrano CV; Ramires JAF; Kalil Filho R
    JAMA Netw Open; 2020 Jan; 3(1):e1919666. PubMed ID: 31968117
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Slow response to loss of glycemic control in type 2 diabetes mellitus.
    Brown JB; Nichols GA
    Am J Manag Care; 2003 Mar; 9(3):213-7. PubMed ID: 12643338
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prevalence of inadequate glycemic control among patients with type 2 diabetes in the United Kingdom general practice research database: A series of retrospective analyses of data from 1998 through 2002.
    Fox KM; Gerber Pharmd RA; Bolinder B; Chen J; Kumar S
    Clin Ther; 2006 Mar; 28(3):388-95. PubMed ID: 16750453
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Self-awareness of HbA1c and its association with glycemic control among patients with type 2 diabetes: A multicenter study.
    Almutairi JS; Almigbal TH; Alruhaim HY; Mujammami MH; AlMogbel TA; Alshahrani AM; Al Zahrani AM; Batais MA; Shaik SA
    Saudi Med J; 2022 Mar; 43(3):291-300. PubMed ID: 35256497
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Initial Glycemic Control and Care Among Younger Adults Diagnosed With Type 2 Diabetes.
    Gopalan A; Mishra P; Alexeeff SE; Blatchins MA; Kim E; Man A; Karter AJ; Grant RW
    Diabetes Care; 2020 May; 43(5):975-981. PubMed ID: 32132007
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A statistical model to identify determinants of glycemic control in patients with type 2 diabetes with different pharmacotherapeutic profiles.
    Moura AM; Antunes M; Martins SO; Raposo JF
    PLoS One; 2020; 15(7):e0235376. PubMed ID: 32629460
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Correlation between baseline characteristics and clinical outcomes in a large population of diabetes patients treated with liraglutide in a real-world setting in Italy.
    Lapolla A; Frison V; Bettio M; Dal Pos M; Rocchini P; Panebianco G; Tadiotto F; Da Tos V; D'Ambrosio M; Marangoni A; Ferrari M; Pianta A; Balzano S; Confortin L; Lamonica M; Marin N; Strazzabosco M; Brun E; Mesturino CA; Simoncini M; Zen F; Bax G; Bonsembiante B; Cardone C; Dal Frà MG; Gallo A; Masin M; Piarulli F; Sartore G; Simioni N
    Clin Ther; 2015 Mar; 37(3):574-84. PubMed ID: 25626486
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cause-specific risk of major adverse cardiovascular outcomes and hypoglycemic in patients with type 2 diabetes: a multicenter prospective cohort study.
    Sun B; He F; Sun L; Zhou J; Shen J; Xu J; Wu B; Liu R; Wang X; Xu H; Chen X; Zhou H; Liu Z; Zhang W
    Endocrine; 2019 Jan; 63(1):44-51. PubMed ID: 30121774
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The Triglyceride/HDL Ratio and Triglyceride Glucose Index as Predictors of Glycemic Control in Patients with Diabetes Mellitus Type 2.
    Babic N; Valjevac A; Zaciragic A; Avdagic N; Zukic S; Hasic S
    Med Arch; 2019 Jun; 73(3):163-168. PubMed ID: 31404127
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Suboptimal glycemic control in adolescents and young adults with type 1 diabetes from 2011 to 2020 across Australia and New Zealand: Data from the Australasian Diabetes Data Network registry.
    James S; Perry L; Lowe J; Harris M; Craig ME;
    Pediatr Diabetes; 2022 Sep; 23(6):736-741. PubMed ID: 35561056
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Baseline Glycated Hemoglobin Values Predict the Magnitude of Glycemic Improvement in Patients with Type 1 and Type 2 Diabetes: Subgroup Analyses from the DIAMOND Study Program.
    Billings LK; Parkin CG; Price D
    Diabetes Technol Ther; 2018 Aug; 20(8):561-565. PubMed ID: 30044123
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Intensified glycemic control by HbA1c for patients with coronary heart disease and Type 2 diabetes: a review of findings and conclusions.
    Chen J; Yin D; Dou K
    Cardiovasc Diabetol; 2023 Jun; 22(1):146. PubMed ID: 37349787
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Association Between Baseline Glycemic Markers (HbA1c) and 8-Year Trajectories of Functional Disability.
    Mutambudzi M; Díaz-Venegas C; Menon S
    J Gerontol A Biol Sci Med Sci; 2019 Oct; 74(11):1828-1834. PubMed ID: 30958520
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.